This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doellgast, G J
Right arrow Articles by Triscott, M X
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doellgast, G J
Right arrow Articles by Triscott, M X

 Previous Article  |  Next Article 

J Clin Microbiol. 1994 January; 32(1): 105-111

Enzyme-linked immunosorbent assay and enzyme-linked coagulation assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual-label antibodies.

G J Doellgast, G A Beard, J D Bottoms, T Cheng, B H Roh, M G Roman, P A Hall and M X Triscott

Department of Biochemistry, Wake Forest University Medical Center, Winston-Salem, North Carolina 27157-1016.

ABSTRACT

The measurement of toxins A, B, and E from Clostridium botulinum was accomplished by use of a modified sandwich enzyme-linked immunosorbent assay (ELISA) employing labeled horse antibody and either chicken antibody or biotinylated horse antibody. The complexes formed in solution phase were captured onto solid phases coated with rabbit anti-chicken immunoglobulin G (chicken antibody) or avidin (biotinylated antibody). The assay was brought to the sensitivity of the mouse bioassay (5 to 10 pg/ml, or 0.03 to 0.07 pM) by employing as labeling enzyme the factor X activator of Russell's viper venom (RVV-XA) and a sensitive coagulation-based assay amplification system known as enzyme-linked coagulation assay. Complex formation was found to be a slower reaction than binding to the capture plate, and so the assay used a preincubation step to produce the solution-phase complexes before they were bound to the solid phase. Keeping the concentrations of Russell's viper venom factor X activator antibody and capture antibody constant for diluted samples and diluting complexes into buffer without keeping labeled antibody concentrations constant were equivalent in allowing the detection of low neurotoxin concentrations. This ELISA-enzyme-linked coagulation assay procedure is a convenient alternative to the mouse bioassay, which shows complete resolution of the neurotoxins in addition to the requisite sensitivity.


J Clin Microbiol. 1994 January; 32(1): 105-111




This article has been cited by other articles:

  • Lindstrom, M., Korkeala, H. (2006). Laboratory Diagnostics of Botulism. Clin. Microbiol. Rev. 19: 298-314 [Abstract] [Full Text]  
  • Sharma, S. K., Ferreira, Joseph. L., Eblen, B. S., Whiting, R. C. (2006). Detection of Type A, B, E, and F Clostridium botulinum Neurotoxins in Foods by Using an Amplified Enzyme-Linked Immunosorbent Assay with Digoxigenin-Labeled Antibodies. Appl. Environ. Microbiol. 72: 1231-1238 [Abstract] [Full Text]  
  • Horman, A., Nevas, M., Lindstrom, M., Hanninen, M.-L., Korkeala, H. (2005). Elimination of Botulinum Neurotoxin (BoNT) Type B from Drinking Water by Small-Scale (Personal-Use) Water Purification Devices and Detection of BoNT in Water Samples. Appl. Environ. Microbiol. 71: 1941-1945 [Abstract] [Full Text]